Open AccessImmunogenicity and safety of a quadrivalent meningococcal polysaccharide CRM conjugate vaccine in infants and toddlers
Author(s) -
Miguel Tregnaghi,
Pío López,
Daniel Stamboulián,
Gabriela Graña,
Tatjana Odrljin,
Lisa Bedell,
Peter Dull
Publication year - 2014
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2014.03.1390
Subject(s) - toddler , medicine , reactogenicity , immunogenicity , conjugate vaccine , concomitant , regimen , neisseria meningitidis , meningococcal vaccine , vaccination , immunology , pediatrics , immunization , immune system , biology , psychology , developmental psychology , bacteria , genetics
This phase III study assessed the safety and immunogenicity of MenACWY-CRM, a quadrivalent meningococcal conjugate vaccine, administered with routine vaccines starting at 2 months of age.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom